...
首页> 外文期刊>Integrative cancer therapies >Induction of apoptosis of tumor cells by some potentiated homeopathic drugs: Implications on mechanism of action
【24h】

Induction of apoptosis of tumor cells by some potentiated homeopathic drugs: Implications on mechanism of action

机译:某些顺势疗法药物诱导肿瘤细胞凋亡:对作用机制的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Background. Homoeopathic medicines treat diseases, including cancer, using ultradiluted preparations. Earlier studies indicated that homoeopathic medicines are cytotoxic to tumor cells and reduced animal tumors. However, the mechanism of homoeopathic medicines at the cellular level is not known. Methods. The following drugs were used in the study: Ruta 200C, Carcinosinum 200C, Hydrastis 200C, Thuja 200C, and Thuja 1M. These drugs were tested for their ability to induce apoptosis as seen by morphology, DNA laddering, expression of genes related to apoptosis, and TUNEL assay. Similarly, the effect of homoeopathic medicines on apoptosis was measured by microarray analysis. Activity of Ruta 200C was compared with that of the mother tincture. Results. Ruta 200C produced morphological changes in the Dalton's lymphoma ascites tumor cells and induced DNA laddering. Carcinosinum 200C increased apoptotic gene p53 and Ruta 200C decreased antiapoptotic gene Bcl2. Administration of potentiated homoeopathic drugs to tumor-bearing mice induced TUNEL-positive cells in the tumor, showing increased apoptosis of tumor cells. Microarray analysis of cells treated with homoeopathic drugs indicated that many enzymes related to apoptosis were increased by homoeopathic drugs. Conclusion. These data indicate that apoptosis is one of the mechanisms of tumor reduction of homeopathic drugs. A comparison of potentiated drugs with their mother tincture indicated that the potentiated drugs have biological activity similar to that of their mother tincture in spite of ultradilution.
机译:背景。顺势疗法药物使用超稀释的制剂治疗包括癌症在内的疾病。较早的研究表明,顺势疗法药物对肿瘤细胞具有细胞毒性,并减少了动物肿瘤。但是,在细胞水平上同源疗法药物的机制尚不清楚。方法。在研究中使用了以下药物:Ruta 200C,Carcinosinum 200C,Hydrastis 200C,Thuja 200C和Thuja 1M。通过形态学,DNA梯形,与细胞凋亡相关的基因表达和TUNEL测定法,测试了这些药物诱导细胞凋亡的能力。类似地,通过微阵列分析测量同种疗法药物对细胞凋亡的作用。将Ruta 200C的活性与母tin的活性进行比较。结果。 Ruta 200C在道尔顿淋巴瘤腹水肿瘤细胞中产生形态学变化,并诱导DNA梯形化。 Carcinosinum 200C增加凋亡基因p53,Ruta 200C减少抗凋亡基因Bcl2。向荷瘤小鼠施用增强的顺势疗法药物可诱导肿瘤中的TUNEL阳性细胞,显示肿瘤细胞凋亡增加。对用同种疗法药物处理的细胞进行的微阵列分析表明,同种疗法药物增加了许多与细胞凋亡相关的酶。结论。这些数据表明凋亡是顺势疗法药物减少肿瘤的机制之一。增强药物与其母mother的比较表明,尽管进行了超稀释,但增强药物的生物学活性类似于其母tin。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号